Pfizer Recalls BP Drugs Because of Potential Carcinogen Pfizer Recalls BP Drugs Because of Potential Carcinogen

The voluntary nationwide recall of the antihypertensive Accuretic and two generics was prompted by unacceptable levels of N-nitroso-quinapril, a likely carcinogen, in 11 lots.News Alerts
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news